Innate Pharma Highlights FDA-Approved Lumoxiti® at ASH 2019
December 08, 2019 09:00 ET
|
INNATE PHARMA
MARSEILLE, France, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) shared new, long-term data from the pivotal...
Karyopharm Presents XPOVIO® (Selinexor) and Eltanexor Data at the American Society of Hematology 2019 Annual Meeting
December 08, 2019 09:00 ET
|
Karyopharm Therapeutics Inc.
-- Once-Weekly Oral Selinexor in Combination with Weekly Kyprolis® and Low Dose Dexamethasone Demonstrates 71% Overall Response Rate, Including a Complete Response Rate of 21%, in Patients with...
Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
December 08, 2019 09:00 ET
|
Agios Pharmaceuticals, Inc.
– Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in 7 of 8 Evaluable Patients – – Safety Profile Consistent with Previously Published Phase 2 Data for Mitapivat in Patients with...
TG Therapeutics Announces Oral Presentation of Umbralisib, Ublituximab and Venetoclax Triple Combination Phase I/II Data in Relapsed/Refractory CLL at the 61st American Society of Hematology Annual Meeting and Exposition
December 08, 2019 09:00 ET
|
TG Therapeutics, Inc.
100% overall response rate (ORR) in relapsed/refractory CLL patients treated with U2 (umbralisib + ublituximab) plus venetoclax at cycle 7 (n=13) 100% of patients (n=9) achieved undetectable MRD in...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Brooks Automation, Inc. - BRKS
December 08, 2019 09:00 ET
|
Pomerantz LLP
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brooks Automation, Inc. (“Brooks” or the “Company”) (NASDAQ: BRKS). Such investors are...
Ziopharm Oncology Presents Pre-Clinical Data Validating “Rapid Personalized Manufacture” (RPM) with TCR at the 2019 American Society for Hematology Annual Meeting
December 08, 2019 09:00 ET
|
ZIOPHARM Oncology Inc
– Membrane bound IL-15 (mbIL15) improves anti-tumor effect of TCR-modified T cells – – T cells expressing T-cell receptor (TCR) and mbIL15 can be infused day after gene transfer – BOSTON, Dec. ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Yunji Inc. - YJ
December 08, 2019 08:00 ET
|
Pomerantz LLP
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ). Such investors are advised to...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Resideo Technologies, Inc. - REZI
December 08, 2019 08:00 ET
|
Pomerantz LLP
NEW YORK, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Resideo Technologies, Inc. (“Resideo” or the “Company”) (NYSE: REZI). Such investors are...
New data demonstrate the continued clinical benefit of fixed-duration, chemotherapy-free Venclexta/Venclyxto-based treatments in chronic lymphocytic leukaemia
December 08, 2019 07:30 ET
|
F. Hoffmann-La Roche Ltd
In an updated analysis of the CLL14 study, Venclexta/Venclyxto plus Gazyva/Gazyvaro achieved remissions that were sustained over time in people with previously untreated chronic lymphocytic leukaemia...
About the listing of Coop Pank shares on Baltic Main List
December 08, 2019 07:16 ET
|
Coop Pank AS
Company Announcement 8 December 2019 Nasdaq has announced today that Coop Pank AS shares (trading ticker: CPA1T) will be listed on the Baltic Main List on Tuesday, December 10, 2019. Further...
- June 15, 2024 08:57 ET MULTIMEDIA UPDATE -- Rygen Technologies Launches Next-Gen Supply Chain Solution: AI-enabled TMS
- June 14, 2024 21:21 ET Pik'r Range Picking Robot Enhances U.S. Open Experience at Pinehurst